← Back to Clinical Trials
Recruiting NCT04266418

The Evaluation of Banana Flower Stamens Extract on Prevention of Benign Prostatic Hyperplasia in Adults

Trial Parameters

Condition Benign Prostatic Hyperplasia (BPH)
Sponsor TCI Co., Ltd.
Study Type INTERVENTIONAL
Phase N/A
Enrollment 50
Sex MALE
Min Age 40 Years
Max Age 80 Years
Start Date 2023-03-01
Completion 2025-12-31
Interventions
PlaceboBanana flower stamens extract

Brief Summary

To assess the evaluation of banana flower stamens extract on prevention of benign prostatic hyperplasia in adults

Eligibility Criteria

Inclusion Criteria: 1. Male aged 40-80 years old 2. 7 ≤ IPSS score \<19 3. The subject did not take α-blocker or anticholinergic agents in the last 8 weeks. The subject did not take 5α-reductase inhibitor or androgen suppression agents in the last 16 weeks (depending on medical history). 4. The subject isn't diagnosed with cancer 5. The subject is able to read and finish the information on the questionnaire. 6. The subject must read and sign the informed consent form after the study has been fully explained. Exclusion criteria: 1. The subject has a history of epilepsy or convulsions, liver and kidney disease, cancer, endocrine disease, mental illness, alcohol or drug abuse, and other major organic diseases (depending on medical history). 2. The lower urinary tract urination symptoms of the subject are not related to prostatic hypertrophy (depending on medical history). 3. Residual urine volume \> 250 mL (depending on medical history) 4. Subjects have had pelvic radiation therapy or pel

Related Trials